Potential Seaweed-Derived Bioactive Compounds for Pharmaceutical Applications

Seaweeds, also known as marine macroalgae, have been recognized for centuries as a valuable resource with diverse applications. The pharmaceutical industry is increasingly seeking novel, natural compounds for drug development. Seaweeds are rich sources of bioactive compounds, such as polysaccharides, polyphenols, peptides, and lipids, which exhibit a wide range of biological activities. This chapter explores the potential of seaweed-derived bioactive compounds for pharmaceutical applications and their antiviral, antibacterial, anti-inflammatory, antioxidant, and anticancer capabilities, underscoring their potential in combatting a spectrum of ailments. For diabetes, these compounds have been shown to possess hypoglycemic properties, contributing to the regulation of blood sugar levels and aid in weight management. Further, they control cell growth and initiate angiogenesis, cutting off blood supply to tumors showing potent anticancer effects. The immunomodulatory and neuroprotective effects have also been discussed, broadening the scope of their application. Finally, the chapter advocates for further research in the field to fully realize the potential of seaweed-derived bioactive compounds as groundbreaking drugs and transformative therapies, revolutionizing the landscape of modern medicine.